Skip to main content

From the Media: Update on the Vaccine Integrity Project

Post
From the Media: Update on the Vaccine Integrity Project
August 26, 2025

Launched in April 2025, the Center for Infectious Disease Research and Policy’s (CIDRAP) Vaccine Integrity Project (VIP) is an initiative dedicated to safeguarding vaccine use in the U.S. The project first engaged a broad array of stakeholders — including public health officials, academia, insurers, medical associations, industry representatives, and community organizations — to assess anticipated gaps and challenges in the vaccine ecosystem. The project recently issued a report that identifies three areas of work to support healthcare providers. These areas are related to rapid communications, contributing to evidence-based recommendations for the upcoming respiratory season, and supporting cross-sector coordination and collaboration. 

These foci aim to help those on the front lines as follows: 

  1. Stay abreast of the latest information. VIP’s communications strategy will work to uphold public trust and provide accurate, real-time information, increasing the opportunity for frontline providers to use evidence-based messaging when countering inaccurate information.
  2. Have a source of reference for emerging clinical guidance. Frontline providers will be assured that 2025-2026 respiratory virus recommendations and guidelines from the professional societies are evidence-based.
  3. Participate in collaborative networks. By fostering collaboration across sectors, VIP’s efforts seek to ensure a coordinated vaccine infrastructure. 

Stay abreast of the latest news and information by subscribing to the daily newsletter from VIP’s parent organization, CIDRAP.

Read the full report.

Jump back to top